Global Aesthetic Medicine Market Report 2022 to 2030: Increasing Adoption of Minimally Invasive Treatments Drives Growth – ResearchAndMarkets.com

Global Aesthetic Medicine Market Report 2022 to 2030: Increasing Adoption of Minimally Invasive Treatments Drives Growth – ResearchAndMarkets.com




Global Aesthetic Medicine Market Report 2022 to 2030: Increasing Adoption of Minimally Invasive Treatments Drives Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Aesthetic Medicine Market Share, Size, Trends, Industry Analysis Report, By Procedure, By End-Use, Segment Forecast, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering.

The global aesthetic medicine market size is expected to reach USD 304.82 billion by 2030, according to a new study. The report gives a detailed insight into current market dynamics and provides analysis on future market growth.

The main elements anticipated to propel market revenue growth includes the patients having mastectomy, thereby driving the cosmetic medical procedures, with constant focus on the rapid development of minimally invasive and non-invasive aesthetic solutions.

In developing nations, demand for aesthetic treatments has surged due to a growing desire to seem young and fit. In nations like India and South Korea, consumers are becoming more interested in aesthetic procedures like liposuction, nose reshaping, and Botox injections. According to the 2020 International Society of Aesthetic Plastic Surgery (ISAPS) report, 6,213,859 Botulinum Toxin, and 1,225,540 eyelid surgeries were performed worldwide.

The market for aesthetic medicine was significantly impacted by the COVID-19 pandemic. Social alienation and a rapid, sharp decrease in consumer income levels had initially hurt the market. Due to factors such a decline in product demand, operational restrictions, the temporary closure of beauty salons, and disruptions in the supply and manufacturing chains, the industry has seen short-term negative growth.

Due to doctors’, healthcare providers’ (HCPs), patients’, and other stakeholders’ quick outreach via social media channels and other digital platforms, approval for cosmetic medical operations has grown tremendously over the past several years. This has improved communication between HCPs and those who are wary about undergoing such operations.

In the upcoming years, it is anticipated that this will lead to a greater acceptance of aesthetic medicine tools and products. Manufacturers of cosmetic medicinal formulations are able to satisfy consumer requests by researching regional consumer needs.

For instance, India was listed as one of the top 5 countries providing non-surgical procedures globally in the International Society of Aesthetic Plastic Surgery (ISAPS) 2020 report. This demonstrates the promising future for the nation’s producers of aesthetic medicine.

Aesthetic Medicine Market Report Highlights

  • Non-invasive procedures held the largest revenue share in 2021. The segment is expected to experience the fastest CAGR growth during the projection period. Globally, people are becoming more interested in non-invasive procedures due to factors including reduced pain, quick results, and inexpensive cost.
  • A large portion of the global market is anticipated to be accounted for by beauty centers due to factors like the expansion of these facilities and growing consumer awareness of skin conditions.
  • During the projection period, Asia Pacific is expected to grow at the fastest CAGR. Countries like South Korea, China, and India support the region. One of the main factors anticipated to propel the market in the area is the availability of technologically improved goods, the growing emphasis on appearance, and South Korea’s status as the center of cosmetic surgery.
  • The market is extremely competitive because to the presence of key market players with global presence such as Allergan-AbbVie, Alma Lasers, Anika Therapeutics, Cutera, Cynosure, Fotona, and Solta Medical business.

Market Dynamics

Drivers and Opportunities

  • Increasing adoption of minimally invasive treatments
  • Growing population aged between 25 and 65 years

Restraints and Challenges

  • Lack of reimbursement coverage

Companies Mentioned

  • Allergan-AbbVie
  • Alma Lasers
  • Anika Therapeutics
  • Cutera
  • Cynosure
  • Fotona
  • Galderma
  • Johnson & Johnson
  • Merz Pharma
  • Medytox
  • Sientra
  • Sinclair Pharma
  • Syneron Medical
  • Baush and Solta Medical

For more information about this report visit https://www.researchandmarkets.com/r/myyc2p

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900